Venus Concept Inc. (VERO)
USD 2.47
(3.35%)
USD 2.47
(3.35%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -37.25 Million USD | 14.53% |
| 2022 | -43.58 Million USD | -96.85% |
| 2021 | -22.14 Million USD | 73.27% |
| 2020 | -82.81 Million USD | -95.81% |
| 2019 | -42.29 Million USD | -47.24% |
| 2018 | -28.72 Million USD | -61.0% |
| 2017 | -17.84 Million USD | 18.33% |
| 2016 | -21.84 Million USD | 4.9% |
| 2015 | -22.97 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -19.95 Million USD | -103.71% |
| 2024 Q1 | -9.79 Million USD | 11.89% |
| 2023 Q3 | -9.06 Million USD | -22.39% |
| 2023 Q4 | -11.11 Million USD | -22.58% |
| 2023 Q2 | -7.4 Million USD | 23.01% |
| 2023 FY | -37.25 Million USD | 14.53% |
| 2023 Q1 | -9.62 Million USD | 3.19% |
| 2022 FY | -43.58 Million USD | -96.85% |
| 2022 Q4 | -9.94 Million USD | 31.43% |
| 2022 Q3 | -14.49 Million USD | -37.9% |
| 2022 Q2 | -10.51 Million USD | -21.72% |
| 2022 Q1 | -8.63 Million USD | -99.31% |
| 2021 Q2 | 377 Thousand USD | 104.07% |
| 2021 Q1 | -9.25 Million USD | 36.95% |
| 2021 FY | -22.14 Million USD | 73.27% |
| 2021 Q3 | -9.79 Million USD | -2698.94% |
| 2021 Q4 | -4.33 Million USD | 55.78% |
| 2020 Q3 | -7.24 Million USD | 24.46% |
| 2020 Q2 | -9.58 Million USD | 80.9% |
| 2020 FY | -82.81 Million USD | -95.81% |
| 2020 Q4 | -14.68 Million USD | -102.75% |
| 2020 Q1 | -50.19 Million USD | -141.34% |
| 2019 Q4 | -20.79 Million USD | -125.65% |
| 2019 FY | -42.29 Million USD | -47.24% |
| 2019 Q3 | -9.21 Million USD | -16.78% |
| 2019 Q2 | -7.89 Million USD | -6.08% |
| 2019 Q1 | -7.44 Million USD | 6.78% |
| 2018 Q1 | -7.43 Million USD | -598.4% |
| 2018 Q2 | -6.24 Million USD | 15.97% |
| 2018 Q3 | -7.06 Million USD | -13.21% |
| 2018 Q4 | -7.98 Million USD | -12.9% |
| 2018 FY | -28.72 Million USD | -61.0% |
| 2017 Q1 | -5.17 Million USD | -4.91% |
| 2017 FY | -17.84 Million USD | 18.33% |
| 2017 Q2 | -5 Million USD | 3.25% |
| 2017 Q3 | -6.59 Million USD | -31.74% |
| 2017 Q4 | -1.06 Million USD | 83.87% |
| 2016 FY | -21.84 Million USD | 4.9% |
| 2016 Q3 | -5.92 Million USD | 0.0% |
| 2016 Q4 | -4.93 Million USD | 16.78% |
| 2015 FY | -22.97 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 39.547% |
| BrainsWay Ltd. | -4.19 Million USD | -787.539% |
| Cerus Corporation | -37.48 Million USD | 0.638% |
| Envoy Medical, Inc. | -29.9 Million USD | -24.549% |
| electroCore, Inc. | -18.83 Million USD | -97.781% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -320.904% |
| IceCure Medical Ltd | -14.65 Million USD | -154.232% |
| Inogen, Inc. | -102.44 Million USD | 63.64% |
| OrthoPediatrics Corp. | -20.97 Million USD | -77.601% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 29.271% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -171.003% |
| MaxCyte, Inc. | -37.92 Million USD | 1.775% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -214.094% |
| Nexalin Technology, Inc. | -4.64 Million USD | -701.298% |
| Orthofix Medical Inc. | -151.39 Million USD | 75.395% |
| PAVmed Inc | -64.17 Million USD | 41.956% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 29.003% |
| RxSight, Inc. | -48.6 Million USD | 23.367% |
| Sight Sciences, Inc. | -55.54 Million USD | 32.94% |
| SI-BONE, Inc. | -43.33 Million USD | 14.044% |
| TELA Bio, Inc. | -46.66 Million USD | 20.174% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 24.788% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -174.24% |
| Acutus Medical, Inc. | -81.66 Million USD | 54.386% |
| Talis Biomedical Corporation | -62 Million USD | 39.926% |
| Spectral AI, Inc. | -20.85 Million USD | -78.623% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 38.709% |
| CVRx, Inc. | -41.19 Million USD | 9.585% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 5918.531% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -240.018% |
| Bioventus Inc. | -156.23 Million USD | 76.157% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 36.905% |
| LivaNova PLC | 17.54 Million USD | 312.299% |
| 908 Devices Inc. | -36.39 Million USD | -2.338% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 80.042% |
| Nemaura Medical Inc. | -14.14 Million USD | -163.367% |
| NeuroPace, Inc. | -32.95 Million USD | -13.029% |
| LENSAR, Inc. | -14.38 Million USD | -158.986% |
| Apyx Medical Corporation | -18.71 Million USD | -99.059% |
| Cutera, Inc. | -162.83 Million USD | 77.124% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -243.952% |
| BioSig Technologies, Inc. | -29.04 Million USD | -28.267% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 54.94% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | -68.636% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 154.989% |
| Axonics, Inc. | -6.08 Million USD | -511.859% |
| Outset Medical, Inc. | -172.79 Million USD | 78.443% |
| IRIDEX Corporation | -9.57 Million USD | -289.237% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 64.824% |
| IRadimed Corporation | 17.19 Million USD | 316.661% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -351.844% |
| INVO Bioscience, Inc. | -8.03 Million USD | -363.619% |
| Telesis Bio, Inc. | -47.72 Million USD | 21.947% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 463.663% |
| Varex Imaging Corporation | -47.7 Million USD | 21.908% |
| Quipt Home Medical Corp. | -2.78 Million USD | -1238.003% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -230.055% |
| Pulmonx Corporation | -60.84 Million USD | 38.777% |
| Dynatronics Corporation | -2.69 Million USD | -1280.796% |
| Modular Medical, Inc. | -17.47 Million USD | -113.223% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -227.127% |
| Semler Scientific, Inc. | 20.58 Million USD | 280.975% |
| InMode Ltd. | 197.91 Million USD | 118.821% |
| Bruker Corporation | 427.2 Million USD | 108.72% |
| Cytosorbents Corporation | -28.5 Million USD | -30.668% |
| DexCom, Inc. | 541.5 Million USD | 106.879% |
| Align Technology, Inc. | 445.05 Million USD | 108.37% |
| Viveve Medical, Inc. | -22.02 Million USD | -69.111% |
| ZimVie Inc. | -393.28 Million USD | 90.528% |
| Movano Inc. | -29.28 Million USD | -27.207% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -206.635% |
| Nexalin Technology, Inc. | -4.64 Million USD | -701.298% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 5918.531% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 83.267% |
| Profound Medical Corp. | -28.56 Million USD | -30.386% |
| Insulet Corporation | 206.3 Million USD | 118.056% |
| enVVeno Medical Corporation | -23.51 Million USD | -58.403% |
| Surmodics, Inc. | -11.54 Million USD | -222.734% |
| iCAD, Inc. | -4.84 Million USD | -668.517% |
| Nuwellis, Inc. | -20.2 Million USD | -84.324% |
| Biotricity, Inc. | -14.09 Million USD | -164.292% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 69.815% |
| Aethlon Medical, Inc. | -12.2 Million USD | -205.123% |
| InspireMD, Inc. | -19.91 Million USD | -87.036% |
| PAVmed Inc. | -64.17 Million USD | 41.956% |
| BIOLASE, Inc. | -20.63 Million USD | -80.545% |
| Beyond Air, Inc. | -60.24 Million USD | 38.166% |
| FONAR Corporation | 10.56 Million USD | 452.499% |
| AxoGen, Inc. | -21.71 Million USD | -71.533% |
| Vivani Medical, Inc. | -25.65 Million USD | -45.213% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 230.633% |
| Inari Medical, Inc. | -1.63 Million USD | -2176.895% |
| UFP Technologies, Inc. | 44.92 Million USD | 182.918% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -625.791% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -463.949% |
| Tenon Medical, Inc. | -15.58 Million USD | -139.073% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -141.475% |
| Co-Diagnostics, Inc. | -35.33 Million USD | -5.426% |
| AdaptHealth Corp. | -678.89 Million USD | 94.513% |
| Sintx Technologies, Inc. | -8.25 Million USD | -351.023% |
| NanoVibronix, Inc. | -3.71 Million USD | -903.773% |
| Quanterix Corporation | -32.33 Million USD | -15.204% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -230.055% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 7780.412% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 87.856% |
| TransMedics Group, Inc. | -25.02 Million USD | -48.833% |
| ReWalk Robotics Ltd. | -22.13 Million USD | -68.301% |
| NeuroMetrix, Inc. | -6.52 Million USD | -470.489% |
| Hyperfine, Inc. | -44.23 Million USD | 15.796% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 52.549% |
| Biomerica, Inc. | -5.97 Million USD | -523.118% |
| Bone Biologics Corporation | -8.94 Million USD | -316.26% |
| AVITA Medical, Inc. | -39.16 Million USD | 4.897% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -274.226% |
| Silk Road Medical, Inc | -55.74 Million USD | 33.175% |